Earnings History Data for GT Biopharma, Inc. (GTBP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
GT Biopharma, Inc.
GT Biopharma Inc. is an immuno-oncology company. It discovers, develops and commercializes drugs of therapeutic molecules for the treatment of cancer, myeloma, osteolytic lesions and other unmet medical needs. GT Biopharma Inc., formerly known as OXIS International Inc., is based in Tampa, Florida.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15-05-2024 | AH | GTBP | GT Biopharma | 4.00 | -2.12 | -2.70 | 0.00 | GT Biopharma reports Q1 results [5/15/2024 5:41 PM] |
3.17 | 0.12 (3.93%) |
0.0 | 0.0 (0.00%) |
2.95 - 16.11 | 12,036 | 10,000 | 0 | ||
| 01-11-2023 | PM | GTBP | GT Biopharma | 10.00 | -0.06 | -0.10 | 0.00 | GT Biopharma GAAP EPS of -$0.06 [11/1/2023 9:35 AM] |
0.25 | 0.0 (0.36%) |
0.0 | 0.0 (0.00%) |
0.18 - 2.30 | 56,198 | 80,000 | 0 | ||
| 07-08-2023 | PM | GTBP | GT Biopharma | 10.00 | -0.09 | -0.10 | 0.00 | GT Biopharma GAAP EPS of -$0.05 [8/7/2023 10:52 AM] |
0.2859 | 0.02 (7.04%) |
0.0 | 0.0 (0.00%) |
0.18 - 3.00 | 220,930 | 200,000 | 0 | ||
| 31-10-2022 | AH | GTBP | GT Biopharma | 56.00 | -0.22 | -0.11 | 0.00 | GT Biopharma GAAP EPS of -$0.22 misses by $0.11 [10/31/2022 5:27 PM] |
1.92 | 0.06 (3.23%) |
1.86 | 0.0 (0.00%) |
1.46 - 7.48 | 34,745 | 60,000 | 1,002 | ||
| 28-03-2022 | AH | GTBP | GT Biopharma | 90.00 | -0.52 | -0.21 | 0.00 | GT Biopharma reports Q4 results [3/28/2022 4:36 PM] |
3.07 | 0.23 (8.10%) |
2.84 | 0.0 (0.00%) |
2.47 - 19.73 | 123,888 | 130,000 | 198 | ||
| 10-11-2021 | AH | GTBP | OXIS International | 114.00 | -0.17 | -0.21 | 0.00 | GT Biopharma EPS beats by $0.04 [11/10/2021 4:52 PM] |
5.05 | -0.14 (-2.70%) |
5.19 | 0.0 (0.00%) |
2.55 - 19.73 | 384,443 | 450,000 | 984 | ||
| 23-08-2021 | AH | 0:00 AM ET (Aug 13) |
GTBP | Oxis International Inc. | 167.00 | -0.15 | -0.28 | 0.00 | 8.51 | 1.20 (16.42%) |
7.16 | -0.15 (-2.05%) |
2.50 - 19.73 | 776,592 | 300,000 | 3,602 | ||
| 17-05-2021 | AH | GTBP | Oxis International Inc. | 335.00 | -1.83 | -0.25 | 0.00 | GT Biopharma reports Q1 results [5/17/2021 11:46 PM] |
13.15 | 0.64 (5.12%) |
12.05 | -0.46 (-3.68%) |
2.04 - 17.48 | 375,915 | 740,000 | 458 | ||